EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Prevalence and prediction of augmented renal clearance in the neurocritical care population

Aaron M Cook iD, David Li, Melissa A Nestor, Melissa L Thompson Bastin iD

Journal of Neurocritical Care · 28.10.2022 · 15 (2) · 96-103

DOI: 10.18700/jnc.220061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurocritical Care, online erschienen am 28.10.2022. Verfasst von Aaron M Cook und 3 weiteren Autor:innen. Beteiligte Einrichtung: UK HealthCare Pharmacy Services and Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Augmented renal clearance (ARC; creatinine clearance [CrCl] >130 mL/min/1.73 m2) is prevalent in patients with neurological injuries and may influence their exposure to important pharmacological therapies. Little is known about the relationship between estimated and measured CrCl in this population.

Methods

This single-center, prospective, observational cohort study aimed to describe the association between ARC and estimated CrCl and neurological outcomes in a broad neurocritical care population. Prospective patient screening criteria included adults aged 18–85 years, with critical illness due to neurologic causes (such as ischemic stroke or subarachnoid hemorrhage) and lack of renal dysfunction on admission. Patients who had at least one urine CrCl measurement performed within the first 7 days of hospitalization were included. Two cohorts were evaluated: those with ARC and those without ARC.

Results

Fifty-seven patients were included, of whom 49 (86%) exhibited ARC. Subjects with ARC were more likely to be male and had a significantly higher median measured CrCl (201.7 mL/min/1.73 m2) than those without ARC (109.8 mL/min/1.73 m2). The Augmented Renal Clearance in Trauma Intensive Care (ARCTIC) score displayed the strongest association (vs. CrCl equations) with ARC development (area under the receiver operating characteristic curve, 0.648).

Conclusion

The prevalence of ARC in the present study of a broad neurocritical care population appeared to be high (86%). The ARCTIC score had higher sensitivity and specificity for diagnosing ARC than the common serum creatinine-based estimation.

Schlagwörter

Stichwörter der Autor:innen

Aneurysmal subarachnoid hemorrhagePharmacokineticsStrokeTraumatic brain injury

Autor:innen und Institutionen

  • UK HealthCare Pharmacy Services and Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA.
  • Department of Pharmacy Services, University of California, Davis and University of California San Francisco School of Pharmacy, Sacramento, CA, USA.

ORCID-Profile: Aaron M Cook, Melissa L Thompson Bastin

Förderung

  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Cook, A. M., Li, D., Nestor, M. A., & Bastin, M. L. T. (2022). Prevalence and prediction of augmented renal clearance in the neurocritical care population. Journal of Neurocritical Care, 15(2), 96-103. https://doi.org/10.18700/jnc.220061

Vancouver

Cook AM, Li D, Nestor MA, Bastin MLT. Prevalence and prediction of augmented renal clearance in the neurocritical care population. Journal of Neurocritical Care. 2022;15(2):96-103. doi:10.18700/jnc.220061

BibTeX
@article{Cook2022,
  author = {Cook, Aaron M and Li, David and Nestor, Melissa A and Bastin, Melissa L Thompson},
  title = {Prevalence and prediction of augmented renal clearance in the neurocritical care population},
  journal = {Journal of Neurocritical Care},
  year = {2022},
  volume = {15},
  number = {2},
  pages = {96--103},
  doi = {10.18700/jnc.220061}
}
Kostenlos starten →